Dimerization	O
of	O
EGFR	B:C0034802
and	O
HER2	O
induces	O
breast	O
cancer	I:C0006142
cell	O
motility	I:C0007608
through	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	O
induction	O
.	O

Dimerization	O
of	O
EGFR	O
and	O
HER2	B:C0069515
induces	O
breast	O
cancer	I:C0006142
cell	O
motility	I:C0007608
through	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	O
induction	O
.	O

Dimerization	O
of	O
EGFR	O
and	O
HER2	O
induces	O
breast	B:C0006142
cancer	I:C0006142
cell	O
motility	I:C0007608
through	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	O
induction	O
.	O

Dimerization	O
of	O
EGFR	O
and	O
HER2	O
induces	O
breast	O
cancer	I:C0006142
cell	B:C0007608
motility	I:C0007608
through	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	O
induction	O
.	O

Dimerization	O
of	O
EGFR	O
and	O
HER2	O
induces	O
breast	O
cancer	I:C0006142
cell	O
motility	I:C0007608
through	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	O
induction	O
.	O

Dimerization	O
of	O
EGFR	O
and	O
HER2	O
induces	O
breast	O
cancer	I:C0006142
cell	O
motility	I:C0007608
through	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
-	O
dependent	O
ACTA2	B:C2716282
induction	O
.	O

The	O
dimerization	O
of	O
EGFR	B:C0034802
and	O
HER2	O
is	O
associated	O
with	O
poor	O
prognosis	O
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	O
invasion	I:C2699153
compared	O
to	O
when	O
EGFR	O
remains	O
as	O
a	O
homodimer	O
.	O

The	O
dimerization	O
of	O
EGFR	O
and	O
HER2	B:C0069515
is	O
associated	O
with	O
poor	O
prognosis	O
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	O
invasion	I:C2699153
compared	O
to	O
when	O
EGFR	O
remains	O
as	O
a	O
homodimer	O
.	O

The	O
dimerization	O
of	O
EGFR	O
and	O
HER2	O
is	O
associated	O
with	O
poor	O
prognosis	B:C0033325
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	O
invasion	I:C2699153
compared	O
to	O
when	O
EGFR	O
remains	O
as	O
a	O
homodimer	O
.	O

The	O
dimerization	O
of	O
EGFR	O
and	O
HER2	O
is	O
associated	O
with	O
poor	O
prognosis	O
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	B:C2699153
invasion	I:C2699153
compared	O
to	O
when	O
EGFR	O
remains	O
as	O
a	O
homodimer	O
.	O

The	O
dimerization	O
of	O
EGFR	O
and	O
HER2	O
is	O
associated	O
with	O
poor	O
prognosis	O
such	O
as	O
induction	O
of	O
tumor	O
growth	O
and	O
cell	O
invasion	I:C2699153
compared	O
to	O
when	O
EGFR	B:C0034802
remains	O
as	O
a	O
homodimer	O
.	O

However	O
,	O
the	O
mechanism	O
for	O
events	O
after	O
dimerization	O
in	O
breast	B:C0006142
cancer	I:C0006142
models	O
is	O
not	O
clear	O
.	O

We	O
found	O
that	O
expressions	B:C1171362
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	B:C2716282
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	B:C2716282
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	B:C1514559
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	B:C0069515
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	B:C0034802
-	O
positive	O
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	B:C1446409
breast	O
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	B:C0006142
cancer	I:C0006142
cells	O
.	O

We	O
found	O
that	O
expressions	O
of	O
alpha	O
-	I:C2716282
smooth	I:C2716282
muscle	I:C2716282
actin	I:C2716282
(	O
ACTA2	O
)	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
(	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
)	O
significantly	O
increased	O
with	O
transient	O
or	O
stable	O
overexpression	O
of	O
HER2	O
in	O
EGFR	O
-	O
positive	O
breast	O
cancer	I:C0006142
cells	B:C0007634
.	O

ACTA2	B:C2716282
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	O
was	O
also	O
increased	O
in	O
HER2	O
-	O
positive	O
breast	O
cancer	I:C0006142
patients	O
.	O

ACTA2	O
and	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	O
was	O
also	O
increased	O
in	O
HER2	O
-	O
positive	O
breast	O
cancer	I:C0006142
patients	O
.	O

ACTA2	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	B:C1171362
was	O
also	O
increased	O
in	O
HER2	O
-	O
positive	O
breast	O
cancer	I:C0006142
patients	O
.	O

ACTA2	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	O
was	O
also	O
increased	O
in	O
HER2	B:C0069515
-	O
positive	O
breast	O
cancer	I:C0006142
patients	O
.	O

ACTA2	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	O
was	O
also	O
increased	O
in	O
HER2	O
-	O
positive	B:C1446409
breast	O
cancer	I:C0006142
patients	O
.	O

ACTA2	O
and	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
expression	O
was	O
also	O
increased	O
in	O
HER2	O
-	O
positive	O
breast	B:C0006142
cancer	I:C0006142
patients	O
.	O

In	O
contrast	O
,	O
ACTA2	B:C2716282
expression	O
was	O
decreased	O
by	O
HER2	O
siRNA	I:C1099354
.	O

In	O
contrast	O
,	O
ACTA2	O
expression	B:C1171362
was	O
decreased	O
by	O
HER2	O
siRNA	I:C1099354
.	O

In	O
contrast	O
,	O
ACTA2	O
expression	O
was	O
decreased	O
by	O
HER2	B:C1099354
siRNA	I:C1099354
.	O

Next	O
,	O
we	O
investigated	O
the	O
co-relation	O
between	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
and	O
ACTA2	O
expression	O
.	O

Next	O
,	O
we	O
investigated	O
the	O
co-relation	O
between	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
and	O
ACTA2	B:C2716282
expression	O
.	O

Next	O
,	O
we	O
investigated	O
the	O
co-relation	O
between	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
and	O
ACTA2	O
expression	B:C1171362
.	O

Basal	O
ACTA2	B:C2716282
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	B:C1171362
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	B:C0087111
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	B:C1254351
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	B:C0059985
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	B:C1254351
inhibitor	I:C1254351
AG490	O
.	O

Basal	O
ACTA2	O
expression	O
was	O
significantly	O
decreased	O
by	O
treatment	O
with	O
the	O
STAT1	O
inhibitor	I:C1254351
fludarabine	O
or	O
the	O
JAK2	O
inhibitor	I:C1254351
AG490	B:C0381241
.	O

In	O
contrast	O
,	O
ACTA2	B:C2716282
expression	O
was	O
increased	O
by	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
overexpression	O
.	O

In	O
contrast	O
,	O
ACTA2	O
expression	B:C1171362
was	O
increased	O
by	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
overexpression	O
.	O

In	O
contrast	O
,	O
ACTA2	O
expression	O
was	O
increased	O
by	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
overexpression	O
.	O

In	O
contrast	O
,	O
ACTA2	O
expression	O
was	O
increased	O
by	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
overexpression	B:C1514559
.	O

Levels	O
of	O
ACTA2	B:C2716282
,	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
,	O
and	O
HER2	O
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
breast	O
cancer	I:C0006142
patients	O
.	O

Levels	O
of	O
ACTA2	O
,	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
,	O
and	O
HER2	O
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
breast	O
cancer	I:C0006142
patients	O
.	O

Levels	O
of	O
ACTA2	O
,	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
,	O
and	O
HER2	B:C0069515
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
breast	O
cancer	I:C0006142
patients	O
.	O

Levels	O
of	O
ACTA2	O
,	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
,	O
and	O
HER2	O
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	B:C0332167
-	I:C0332167
risk	I:C0332167
breast	O
cancer	I:C0006142
patients	O
.	O

Levels	O
of	O
ACTA2	O
,	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
,	O
and	O
HER2	O
were	O
increased	O
and	O
relapse	O
free	O
survival	O
was	O
decreased	O
in	O
high	O
-	I:C0332167
risk	I:C0332167
breast	B:C0006142
cancer	I:C0006142
patients	O
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	B:C2716282
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	O
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	B:C0007608
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	O
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	B:C2930586
shRNA	I:C2930586
overexpression	O
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	B:C1514559
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	O
in	O
MDA	B:C1512505
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	O
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	B:C0069515
and	O
4T1	O
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

We	O
also	O
investigated	O
the	O
effect	O
of	O
ACTA2	O
on	O
cell	O
motility	I:C0007608
,	O
which	O
was	O
suppressed	O
by	O
ACTA2	O
shRNA	I:C2930586
overexpression	O
in	O
MDA	O
-	I:C1512505
MB231	I:C1512505
HER2	O
and	O
4T1	B:C1512505
mammary	I:C1512505
carcinoma	I:C1512505
cells	I:C1512505
.	O

The	O
number	O
of	O
lung	B:C0034079
metastatic	I:C0034079
nodules	I:C0034079
was	O
significantly	O
decreased	O
in	O
ACTA2	O
knockdown	O
mice	I:C0206745
.	O

The	O
number	O
of	O
lung	O
metastatic	I:C0034079
nodules	I:C0034079
was	O
significantly	O
decreased	O
in	O
ACTA2	B:C2716282
knockdown	O
mice	I:C0206745
.	O

The	O
number	O
of	O
lung	O
metastatic	I:C0034079
nodules	I:C0034079
was	O
significantly	O
decreased	O
in	O
ACTA2	O
knockdown	B:C0206745
mice	I:C0206745
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	B:C2716282
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	B:C0034802
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	B:C0069515
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	B:C0169661
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	B:C0287920
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	B:C0037080
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	B:C2716282
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	B:C1171362
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	B:C0027626
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	B:C0027627
of	O
breast	O
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	B:C0006142
cancer	I:C0006142
cells	O
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrated	O
that	O
induction	O
of	O
ACTA2	O
by	O
EGFR	O
and	O
HER2	O
dimerization	O
was	O
regulated	O
through	O
a	O
JAK2	O
/	O
signal	O
transducer	I:C0287920
and	I:C0287920
activator	I:C0287920
of	I:C0287920
transcription	I:C0287920
1	I:C0287920
signaling	O
pathway	I:C0037080
,	O
and	O
aberrant	O
ACTA2	O
expression	O
accelerated	O
the	O
invasiveness	O
and	O
metastasis	O
of	O
breast	O
cancer	I:C0006142
cells	B:C0007634
.	O

